News and Comments

OSI (OSIP): Congratulation Prohost Subscribers. A Take Over with over 40% Premium.

  Monday, March 01, 2010

OSI (OSIP): Congratulation Prohost Subscribers. A Take Over with over 40% Premium.  More...


Recent Postings


Archive


Tags

Roche (ROCHE) Xoma (XOMA) NEKTAR (NKTR)) IDERA (IDRA) Dendreon (DNDN) Array Pharmaceuticals (ARRY) KERYX (KERX) Mirati Therapeutics (MRTX) Ridaforolimus Benlysta (belimumab) Biogen Idec (BIIB) Jazz Pharmaceuticals (JAZZ) Micromet (MITI) Onyx (ONXX) Biocryst (BCRX) Vertex (VRTX) Galena (GALE) Dynavax (DVAX) Amgen (AMGN) BIOMARIN (BMRN) Intermune (ITMN) Anacor (ANAC) Human Genome Sciences (HGSI) NANTKWEST (NK) Ziofpharm (ZIOP) GlaxoSmithKline (GSK) Revlimid (lenolidamide) AERIE PHARMACEUTICALS Exelixis (EXEL) Roche (RHHBY) Aimmune Therapeutics (AIMT) Cytokinetics (CYTK) HALOZYME (HALO) ARCA (ABIO) Agenus (AGEN Regeneron (REGN) Elan (ELN) Sarepta (SRPT) Illumina (ILMN) Merck (MRK) Valeant Pharmaceuticals International (VRX) Seattle Genetics (SGEN) Sangamo (SGMO) Rapamune Alnylam (ALNY) SUNESIS PHARMACEUTICALS (SNSS) Inovio (INO) Ionis (IONS) ImmunoGen (IMGN) Prosensa (RNA) Auspex (ASPX) Vitae Pharmaceuticals (VTAE) Human Longevity (HLI) Endometrial Cancer GUARDIAN HEALTH SYNTA (SNTA) Agenus (AGEN) C4 Therapeutics Zerenex Theravance (THRX) Intrexon (XON) Tysabri ABBVIE (ABBV) Sanofi (SNY) Anadys (ANDS) Sanofi (SNA) ADVENTRIX (ANX) Incyte (INCY) KITE (KITE) Multiple Myeloma Alder Biopharmaceuticals (ALDR) ISIS (ISIS) OSI (OSIP) CompuGen (CGEN) SERES THERAPEUTICS (MCRB) Intercept (ICPT) Theravance Bio Pharma (TBPH) Pluristem (PSTI) TOKAI (TKAOI) VANDA (VNDA) REGULUS (RGLS) Bristol-Myers Squibb (BMY) ZALTRAP™ galapagos (GLPG) Telaprevir Herceptin Velcade (bortezomib) Gilead (GILD) Prolor Biotech (PBTH) ACADIA (ACAD) Genentech Sequenom (SQNM) Ariad (ARIA) Idenix (IDIX) Trastuzumab-DM1 Sanofi-Aventis (SAN) Abbott Laboratories (ABT) JUNO (JUNO)